MoleculeMind, a startup dedicated to advancing protein design and optimization through artificial intelligence, has closed a $100.0M Series A funding round. The capital will further develop its core offering, MoleculeOS, an AI-powered platform designed to accelerate the identification and generation of proteins with unparalleled efficiency.
The company's technology harnesses data-driven deep learning to optimize macromolecules, with applications spanning from the research and design of peptides, antibodies, and enzymes to protein optimization in chemistry, materials science, synthetic biology, industry, and agriculture. MoleculeMind aims to transform protein-related R&D across these associated industries.
